We are live on ! Find out more
RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $810M
1-Year Est. Return 30.2%
This Fund
S&P 500
This Quarter Est. Return
+2.06%
1 Year Est. Return
+30.2%
3 Year Est. Return
+116.38%
5 Year Est. Return
+153.13%
10 Year Est. Return
+962.25%
AUM
$342M
AUM Growth
+$4.53M
Cap. Flow
+$2.54M
Cap. Flow %
0.74%
Top 10 Hldgs %
27.24%
Holding
105
New
9
Increased
44
Reduced
37
Closed
6

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$8.51M
2
UHS icon
Universal Health Services
UHS
+$7.3M
3
ABBV icon
AbbVie
ABBV
+$6.16M
4
RAD
Rite Aid Corporation
RAD
+$5.54M
5
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$4.74M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$10.6M
2
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$8.41M
3
CELG
Celgene Corp
CELG
+$6.93M
4
BIIB icon
Biogen
BIIB
+$6.92M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$5.75M

Sector Composition

Rank Sector Weight
1 Healthcare 78.72%
2 Financials 1.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZBH icon
101
Zimmer Biomet
ZBH
$18.4B
– –
-23,175
Closed -$2.34M
VAR
102
DELISTED
Varian Medical Systems, Inc.
VAR
– –
-38,773
Closed -$2.83M
IDIX
103
DELISTED
IDENIX PHARMACEUTICALS INC
IDIX
– –
-97,100
Closed -$2.34M
1 2 3 4
5

Similar funds

PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
ACM
Ashford Capital Management Wilmington, Delaware $809M AUM 35.1% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
RIM
Redwood Investment Management Scottsdale, Arizona $805M AUM 15.01% 1-Year Est. Return
GCM
Glendon Capital Management Santa Monica, California $805M AUM 17.91% 1-Year Est. Return
CL
CVFG LLC Shelbyville, Indiana $804M AUM 27.61% 1-Year Est. Return

Rhenman & Partners Asset Management's Q3 2014 Portfolio in Review

As of Q3 2014, Rhenman & Partners Asset Management held 105 positions worth $342M, up 1.3% from $337M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Rhenman & Partners Asset Management's Q3 2014 filing shows 9 new, 44 increased, 37 reduced and 6 closed positions. Its largest new stake was Medtronic: 133,800 shares worth $6.87M. The largest sale was Gilead Sciences, an estimated $10.6M.

By sector, the portfolio is most concentrated in Healthcare at 79% of assets, down from 85% a quarter earlier, followed by Financials.

  • Rhenman & Partners Asset Management's largest Q3 2014 buy was Medtronic: 133,800 shares worth $6.87M.
  • Rhenman & Partners Asset Management added most to Universal Health Services in Q3 2014, an estimated $7.3M increase.
  • Rhenman & Partners Asset Management's biggest Q3 2014 reduction was Gilead Sciences, cutting an estimated $10.6M.
  • Rhenman & Partners Asset Management fully exited Myriad Genetics in Q3 2014, selling an estimated $3.11M.
  • Rhenman & Partners Asset Management's ten largest holdings make up 27% of its $342M portfolio in Q3 2014.
  • Rhenman & Partners Asset Management opened 9 new positions and closed 6 in Q3 2014.
  • Rhenman & Partners Asset Management's portfolio value rose 1.3% quarter-over-quarter to $342M.

Based on Rhenman & Partners Asset Management's 13F filing for Q3 2014, filed 3 Nov 2014.